Dr. Deepak Bhatt and Dr. C. Michael Gibson Discuss: The SOLOIST-WHF and SCORED Trials: Sotagliflozin in Diabetes Patients November 16, 2020 Disclosures: TBA
Dr. A. Michael Lincoff and Dr. C. Michael Gibson Discuss: STRENGTH Trial: Cardiovascular Outcomes With Omega-3 Carboxylic Acids (Epanova) In Patients With High Vascular Risk And Atherogenic Dyslipidemia November 15, 2020
Dr. Otavio Berwanger and Dr. C. Michael Gibson Discuss: Rivaroxaban Versus Warfarin In Patients With Bioprosthetic Mitral Valves And Atrial Fibrillation Or Flutter: Primary Results From The RIVER Randomized Trial November 14, 2020 Disclosures: TBA
Dr. Renato Lopes and Dr. C. Michael Gibson Discuss: Rivaroxaban Versus Warfarin In Patients With Bioprosthetic Mitral Valves And Atrial Fibrillation Or Flutter: Primary Results From The RIVER Randomized Trial November 14, 2020
Dr. Prem Pais and Dr. Serge Korjian Discuss: A Polypill For Primary Prevention Of Cardiovascular Disease In Intermediate Risk People: Results Of The International Polycap Study (TIPS)-3 November 13, 2020
Dr. Salim Yusuf and Dr. C. Michael Gibson Discuss: Aspirin Alone And In Combination With A Polypill In Cardiovascular Disease Primary Prevention: Results From The International Polycap Study (TIPS)-3 November 13, 2020
Dr. Amir Lerman Presents: Defining “Refractory Angina”: Epicardial and Microvascular February 7, 2020 Disclosures: TBA
Dr. Thomas J. Povsic Presents: Autologous CD34+ Cells for Treatment of Refractory Angina February 7, 2020 Disclosures: TBA
Dr. Andreas M. Zeiher Presents: The Future of Cell-Based Therapies of Cardiovascular Diseases February 7, 2020 Disclosures: TBA
Dr. C. Michael Gibson Presents: Advancing Cell Therapies for Coronary Microvascular Dysfunction: Experts Roundtable – Introduction February 7, 2020 Disclosures: TBA
